Search bioRxiv⌕ Search

Biology subjects

Lannes, J.

Publications and source records attributed to Lannes, J..

2 recordsLinked to original sources

Genetic diversity of Legionella species in culture-negative clinical and environmental specimens by sequencing the 23S-5S ribosomal intergenic spacer region

The diagnosis of Legionnaires' disease (LD) caused by Legionella non-pneumophila species is likely to increase with broader use of PCR targeting Legionella spp. In this context, accurate species identification in PCR-positive but culture-negative samples is essential to improve understanding of disease epidemiology and to support source attribution. Here, we presented a validated and user-friendly bioinformatic pipeline compatible with next-generation sequencing (NGS) for analyzing the hypervariable 23S-5S region, paired with a curated database encompassing all described Legionella species as of January 2026. Parameters were optimized for sensitivity and specificity using both strains and culture-positive clinical and environmental samples. We then applied the pipeline retrospectively to 92 culture-negative PCR-positive samples collected from 2023 to 2025. Legionella species were successfully assigned in 60% (55/92) of tested samples and revealed a high diversity. Co-infections were detected in clinical samples, including combinations of L. pneumophila with L. longbeachae or L. bozemanii, while environmental samples contained up to six different species. These results demonstrate that 23S-5S amplicon NGS enables species-level identification in the absence of cultured isolates, improving surveillance of non-pneumophila Legionella cases. The proposed pipeline, implemented in QIIME2 and accompanied by a publicly available database, provides a practical framework for routine molecular monitoring and outbreak investigation.

microbiology↗

MiR-219 deficiency in Alzheimer’s disease contributes to neurodegeneration and memory dysfunction through post-transcriptional regulation of tau-kinase network

Intracellular accumulation of hyperphosphorylated misfolded tau proteins is one of the main neuropathological hallmarks in Alzheimers disease (AD) and related tauopathies. Hence, knowledge and understanding of disease mechanisms altering tau proteostasis and inducing cytotoxicity is critical. MicroRNAs (miRNAs) are capable of binding to and silencing many target transcripts, providing an additional level of regulation that complements canonical transcriptional pathways. Therefore, observed abnormalities in their expression patterns in neurodegeneration suggest alterations of microRNA-target networks as drivers of cellular dysfunction in the disease. Strikingly, here we have found in autopsy brain tissue that miRNA miR-219 expression levels are decreased in a brain region early affected in AD patients, the entorhinal cortex. Our bioinformatics analysis indicates miR-219 is predicted to target Calcium/calmodulin-dependent protein kinase 2 gamma subunit (CAMK2{gamma}), Tau tubulin kinase 1 (TTBK1) and Glycogen synthase kinase 3 beta (GSK3{beta}), which are all implicated in the generation of abnormal hyperphosphorylated tau. We reveal human proteomic data supporting dysregulation in the levels of predicted miR-219 targets in the entorhinal cortex. In mammalian cellular models, we found that downregulation of miR-219 de-repress synthesis of three tau kinases, CAMK2{gamma}, TTBK1 and GSK3{beta} on the post-transcriptional level resulting in tau phosphorylation and cell toxicity. Finally, we show that deficiency of miR-219 in vivo promotes age dependent neurodegeneration in the adult brain, with enhanced alterations in tau proteostasis, presynaptic terminals and memory impairment. Taken together, our data implicate miRNA dysregulation central to AD etiopathogenesis and suggest potential targets for the treatment of AD and related tauopathies.

neuroscience↗